ATE499612T1 - Verwendung eines endoplasmin-fragments und von derivaten davon als biomarker für kolorektaladenom und/oder -karzinom; nachweisverfahren und testsystem - Google Patents
Verwendung eines endoplasmin-fragments und von derivaten davon als biomarker für kolorektaladenom und/oder -karzinom; nachweisverfahren und testsystemInfo
- Publication number
- ATE499612T1 ATE499612T1 AT05778104T AT05778104T ATE499612T1 AT E499612 T1 ATE499612 T1 AT E499612T1 AT 05778104 T AT05778104 T AT 05778104T AT 05778104 T AT05778104 T AT 05778104T AT E499612 T1 ATE499612 T1 AT E499612T1
- Authority
- AT
- Austria
- Prior art keywords
- carcinoma
- colorectal
- colorectal adenoma
- test system
- biomarker
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57496—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving intracellular compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2005/009005 WO2007019875A1 (en) | 2005-08-19 | 2005-08-19 | Use of an endoplasmin fragment and derivatives thereof as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE499612T1 true ATE499612T1 (de) | 2011-03-15 |
Family
ID=36087694
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05778104T ATE499612T1 (de) | 2005-08-19 | 2005-08-19 | Verwendung eines endoplasmin-fragments und von derivaten davon als biomarker für kolorektaladenom und/oder -karzinom; nachweisverfahren und testsystem |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8580489B2 (de) |
| EP (1) | EP1917530B1 (de) |
| JP (1) | JP4832519B2 (de) |
| KR (1) | KR101314959B1 (de) |
| AT (1) | ATE499612T1 (de) |
| AU (1) | AU2005335652A1 (de) |
| BR (1) | BRPI0520483A2 (de) |
| CA (1) | CA2617214C (de) |
| DE (1) | DE602005026587D1 (de) |
| IL (1) | IL189185A0 (de) |
| MX (1) | MX2008001818A (de) |
| NO (1) | NO20080510L (de) |
| WO (1) | WO2007019875A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2489720C2 (ru) * | 2007-02-27 | 2013-08-10 | Сентоклон Интернэшнл Аб | Мультиплексная детекция опухолевых клеток с использованием панели агентов, связывающихся с внеклеточными маркерами |
| CN109584961A (zh) * | 2018-12-03 | 2019-04-05 | 元码基因科技（北京）股份有限公司 | 基于二代测序技术检测血液微卫星不稳定的方法 |
| CN110244047B (zh) * | 2019-06-10 | 2023-11-03 | 广州市妇女儿童医疗中心 | 肺癌血清诊断标志物及其应用、肺癌相关可溶性蛋白的分离鉴定方法 |
| KR20240068432A (ko) * | 2022-11-10 | 2024-05-17 | 을지대학교 산학협력단 | 혈액 내 단백질 바이오마커를 포함하는 암 진단용 키트 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10019967A1 (de) * | 2000-04-20 | 2001-10-25 | Fenning Biomed Gmbh Dr | Antikörper gegen natives gp96, deren Herstellung und Verwendung |
| MXPA05006382A (es) | 2002-12-20 | 2005-10-24 | Hoffmann La Roche | Uso de nicotinamida n-metiltransferasa como un marcador para cancer colorrectal. |
| US8067152B2 (en) * | 2006-02-27 | 2011-11-29 | The Fred Hutchinson Cancer Research Center | Liver cancer biomarkers |
-
2005
- 2005-08-19 MX MX2008001818A patent/MX2008001818A/es active IP Right Grant
- 2005-08-19 DE DE602005026587T patent/DE602005026587D1/de active Active
- 2005-08-19 KR KR1020087006581A patent/KR101314959B1/ko active IP Right Grant
- 2005-08-19 US US11/990,598 patent/US8580489B2/en not_active Expired - Fee Related
- 2005-08-19 CA CA2617214A patent/CA2617214C/en not_active Expired - Fee Related
- 2005-08-19 JP JP2008526379A patent/JP4832519B2/ja not_active Expired - Fee Related
- 2005-08-19 EP EP05778104A patent/EP1917530B1/de not_active Not-in-force
- 2005-08-19 AT AT05778104T patent/ATE499612T1/de not_active IP Right Cessation
- 2005-08-19 WO PCT/EP2005/009005 patent/WO2007019875A1/en active Application Filing
- 2005-08-19 AU AU2005335652A patent/AU2005335652A1/en not_active Abandoned
- 2005-08-19 BR BRPI0520483-6A patent/BRPI0520483A2/pt not_active IP Right Cessation
-
2008
- 2008-01-28 NO NO20080510A patent/NO20080510L/no not_active Application Discontinuation
- 2008-02-03 IL IL189185A patent/IL189185A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1917530A1 (de) | 2008-05-07 |
| JP4832519B2 (ja) | 2011-12-07 |
| US20100273668A1 (en) | 2010-10-28 |
| DE602005026587D1 (de) | 2011-04-07 |
| KR101314959B1 (ko) | 2013-10-11 |
| AU2005335652A1 (en) | 2007-02-22 |
| BRPI0520483A2 (pt) | 2009-11-10 |
| WO2007019875A1 (en) | 2007-02-22 |
| EP1917530B1 (de) | 2011-02-23 |
| KR20080036652A (ko) | 2008-04-28 |
| MX2008001818A (es) | 2008-04-09 |
| NO20080510L (no) | 2008-05-19 |
| IL189185A0 (en) | 2008-06-05 |
| JP2009505080A (ja) | 2009-02-05 |
| CA2617214A1 (en) | 2007-02-22 |
| US8580489B2 (en) | 2013-11-12 |
| CA2617214C (en) | 2013-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005012108D1 (de) | Verwendung von c3a und derivaten als biomarker für kolorektaladenom und/oder -karzinom ; nachweisverfahren und testsystem damit | |
| MX357119B (es) | Microarn plasmáticos para la detección de cáncer colorrectal temprano. | |
| WO2008134526A3 (en) | Glycoprotein profiling of bladder cancer | |
| MX2008009592A (es) | Metodos y composiciones para identificar pacientes con una probabilidad incrementada de tener cancer de ovario. | |
| DE60332639D1 (de) | Verwendung von biomarkern zum nachweis von eierstockkrebs | |
| WO2008109075A3 (en) | Biomarkers and methods for determining sensitivity to ctla-4 antagonists | |
| EP3156925A3 (de) | Copd-biomarkersignaturen | |
| ATE556030T1 (de) | Ultrasensitiver nachweis von analyten | |
| WO2010033371A3 (en) | Molecular markers for lung and colorectal carcinomas | |
| EA200500355A1 (ru) | Способ обнаружения, характеристики и мониторинга углеводородных месторождений | |
| ATE370414T1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
| ATE499612T1 (de) | Verwendung eines endoplasmin-fragments und von derivaten davon als biomarker für kolorektaladenom und/oder -karzinom; nachweisverfahren und testsystem | |
| ATE492815T1 (de) | Diagnostik-biomolekül(e) | |
| DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome | |
| NO20053276L (no) | Fremgangsmate og hjelpemiddel for pavisning av mykoplasma. | |
| WO2014044791A3 (en) | Methods and kits for predicting the sensitivity of a subject to chemotherapy | |
| DK1416278T3 (da) | Fremgangsmåder til forbedret diagnosticering af dysplasier | |
| BRPI0514314A (pt) | método para detecção de e discriminação entre adenoma colorretal e/ou carcinoma colorretal, método para monitoramento de desenvolvimento e/ou curso e/ou de tratamento de adenoma colorretal e/ou carcinoma colorretal, uso de c3a ou derivado do mesmo, sistema de teste, conjunto compreendendo moléculas, método para determinar se um composto é efetivo no tratamento do adenoma colorretal e/ou carcinoma colorretal | |
| EP1852513A3 (de) | Verfahren zur Krebsdiagnose mittels Genmarker für krebsassoziierte Deletionen | |
| RU2007119984A (ru) | Способ контроля аналитической работы при опробовании золоторудных месторождений |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |